Tert-Butyl Formate

Tert-Butyl Formate

SCHEMBL28046972

CC(C)(C)OC=O.NCc1cnc[nH]1

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 9/20 0.43
HRH1 P35367 7/20 0.43
HRH4 Q9H3N8 6/20 0.43
HRH2 P25021 4/20 0.43
LMNA P02545 1/20 0.43
MIF P14174 1/20 0.43
TSHR P16473 1/20 0.43
APEX1 P27695 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
GLA P06280 1/20 0.40
KMT2A Q03164 1/20 0.40
CYP1A2 P05177 1/20 0.40
NFKB1 P19838 1/20 0.40
THPO P40225 1/20 0.40
FDPS P14324 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tert-Butyl Formate SCHEMBL27432795 0.77 ALDH1A1 (0.57) HRH3TDP1MEN1ALDH1A1KMT2A
Hydrochloric Acid SCHEMBL4554002 0.75
Hydrochloric Acid SCHEMBL18226068 0.75
Tert-Butyl Formate SCHEMBL28047090 0.73 USP2 (0.44) HRH2LMNATSHRTDP1
Tert-Butyl Formate SCHEMBL28162959 0.72 CYP3A4 (0.44) SMN1; SMN2TDP1CYP1A2
SCHEMBL27766969 0.71 TDP1 (0.38) HRH3HRH4TDP1MEN1ALDH1A1
Tert-Butyl Formate SCHEMBL27599551 0.70 TDP1 (0.56) HRH3SMN1; SMN2TDP1
Tert-Butyl Formate SCHEMBL28046988 0.70 TDP1 (0.42) TDP1
Tert-Butyl Formate SCHEMBL28825172 0.68 TDP1 (0.43) TDP1
SCHEMBL12083368 0.67 PKM (0.47) HRH3HRH1HRH4HRH2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105307657-A Heteroaryl compounds and uses thereof CELGENE AVILOMICS RES INC 2016-02-03 CN disclosed